M. González-gay and T. Pina, Giant Cell Arteritis and Polymyalgia Rheumatica: an Update, Current Rheumatology Reports, vol.40, issue.3 Suppl 82, p.6, 2015.
DOI : 10.1007/s11926-014-0480-1

J. Chacko, J. Chacko, and M. Salter, Review of Giant cell arteritis, Saudi Journal of Ophthalmology, vol.29, issue.1, pp.48-52, 2015.
DOI : 10.1016/j.sjopt.2014.10.001

H. Petri, A. Nevitt, K. Sarsour, P. Napalkov, and N. Collinson, Incidence of Giant Cell Arteritis and Characteristics of Patients: Data-Driven Analysis of Comorbidities, Arthritis Care & Research, vol.48, issue.Suppl 44, 2015.
DOI : 10.1002/acr.22429

J. Lee, S. Naguwa, G. Cheema, and M. Gershwin, The Geo-epidemiology of Temporal (Giant Cell) Arteritis, Clinical Reviews in Allergy & Immunology, vol.65, issue.1-2, pp.88-95, 2008.
DOI : 10.1007/s12016-008-8075-0

A. Chandran, P. Udayakumar, C. Crowson, K. Warrington, and E. Matteson, The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period, 1950.

K. Larsson, D. Mellström, E. Nordborg, C. Nordborg, A. Odén et al., Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis, Annals of the Rheumatic Diseases, vol.65, issue.4, pp.529-561, 2006.
DOI : 10.1136/ard.2005.039404

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798101

I. Marie, Giant cell arteritis and polymyalgia rheumatica: diagnostic criteria]. Rev Médecine Interne, pp.403-414, 2013.

P. Duhaut, L. Pinède, H. Bornet, S. Demolombe-ragué, C. Dumontet et al., Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease, Annals of the Rheumatic Diseases, vol.58, issue.6, pp.335-376, 1999.
DOI : 10.1136/ard.58.6.335

M. Gonzalez-gay, S. Barros, M. Lopez-diaz, C. Garcia-porrua, A. Sanchez-andrade et al., Giant Cell Arteritis, Medicine, vol.84, issue.5, pp.269-76, 2005.
DOI : 10.1097/01.md.0000180042.42156.d1

J. Schmidt and P. Duhaut, Atteinte aortique dans la maladie de Horton, La Revue de M??decine Interne, vol.37, issue.4, pp.239-283
DOI : 10.1016/j.revmed.2015.12.018

C. Assie and M. I. , Giant cell arteritis-related upper/lower limb vasculitis]. Presse Médicale, Feb, vol.40, issue.2, pp.151-61, 2011.

P. Hatron and M. Lambert, [The two faces of giant cell arteritis], Rev Med Interne, 2016.

M. González-gay, C. García-porrúa, J. Llorca, A. Hajeer, F. Brañas et al., Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients, Medicine, vol.79, issue.5, pp.283-92, 2000.
DOI : 10.1097/00005792-200009000-00001

C. Salvarani, L. Cimino, P. Macchioni, D. Consonni, F. Cantini et al., Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis, Arthritis & Rheumatism, vol.106, issue.2, pp.293-300, 2005.
DOI : 10.1002/art.21075

E. Liozon, F. Herrmann, K. Ly, P. Robert, V. Loustaud et al., Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients, The American Journal of Medicine, vol.111, issue.3, 2001.
DOI : 10.1016/S0002-9343(01)00770-7

B. Bienvenu, K. Ly, M. Lambert, C. Agard, M. André et al., Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA), La Revue de M??decine Interne, vol.37, issue.3, pp.154-65, 2016.
DOI : 10.1016/j.revmed.2015.12.015

C. Mukhtyar, L. Guillevin, M. Cid, B. Dasgupta, K. De-groot et al., EULAR recommendations for the management of large vessel vasculitis, Annals of the Rheumatic Diseases, vol.68, issue.3, 2009.
DOI : 10.1136/ard.2008.088351

C. Au, N. Sharma, P. Mccluskey, and R. Ghabrial, Length of temporal artery biopsies, Clin Experiment Ophthalmol, 2016.

J. Hernández-rodríguez, G. Murgia, I. Villar, E. Campo, S. Mackie et al., Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis, Medicine, vol.95, issue.8, p.2368, 2016.
DOI : 10.1097/MD.0000000000002368

B. Marí, M. Monteagudo, E. Bustamante, J. Pérez, A. Casanovas et al., Analysis of temporal artery biopsies in an 18-year period at a community hospital, European Journal of Internal Medicine, vol.20, issue.5, pp.533-539, 2009.
DOI : 10.1016/j.ejim.2009.05.002

M. Gonzalez-gay, C. Garcia-porrua, J. Llorca, C. Gonzalez-louzao, and P. Rodriguez-ledo, Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy, Seminars in Arthritis and Rheumatism, vol.30, issue.4, pp.249-56, 2001.
DOI : 10.1053/sarh.2001.16650

F. Muratore, A. Cavazza, L. Boiardi, A. Gullo, N. Pipitone et al., Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study, Arthritis Care & Research, vol.26, issue.6, pp.865-70, 2015.
DOI : 10.1002/acr.22736

M. Gonzalez-gay, S. Barros, M. Lopez-diaz, C. Garcia-porrua, A. Sanchez-andrade et al., Giant Cell Arteritis, Medicine, vol.84, issue.5, pp.269-76, 2005.
DOI : 10.1097/01.md.0000180042.42156.d1

G. Hunder, D. Bloch, B. Michel, M. Stevens, W. Arend et al., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis & Rheumatism, vol.33, issue.8, pp.1122-1130, 1990.
DOI : 10.1002/art.1780330810

P. Duhaut and J. Ducroix, Maladie de Horton et pseudopolyarthrite rhizomélique. Traité des maladies et syndromes systémiques. 5e éd. Paris: Flammarion, pp.590-618, 2008.

L. Sailler, G. Pugnet, and B. Bienvenu, [Treatment of giant cell arteritis]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.431-438, 2013.

A. Proven, S. Gabriel, C. Orces, O. Fallon, W. Hunder et al., Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum, pp.703-711, 2003.

C. Weyand and J. Goronzy, Immune mechanisms in medium and large-vessel vasculitis, Nature Reviews Rheumatology, vol.360, issue.12, pp.731-771
DOI : 10.1016/j.ophtha.2009.07.043

O. Neill, L. Molloy, and E. , The role of toll like receptors in giant cell arteritis. Rheumatol, 2016.

W. Ma-krupa, M. Jeon, S. Spoerl, T. Tedder, J. Goronzy et al., Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis, The Journal of Experimental Medicine, vol.42, issue.2, pp.173-83, 2004.
DOI : 10.1002/art.10071

M. Samson and B. Bonnotte, Physiopathologie des vascularites primitives des gros vaisseaux, La Revue de M??decine Interne, vol.37, issue.4, pp.264-73, 2015.
DOI : 10.1016/j.revmed.2015.10.350

C. Weyand, B. Younge, and J. Goronzy, IFN-?? and IL-17: the two faces of T-cell pathology in giant cell arteritis, Current Opinion in Rheumatology, vol.23, issue.1, pp.43-52, 2011.
DOI : 10.1097/BOR.0b013e32833ee946

J. Deng, B. Younge, R. Olshen, J. Goronzy, and C. Weyand, Th17 and Th1 T-cell responses in giant cell arteritis. Circulation, Feb, vol.23121, issue.7, pp.906-921, 2010.
DOI : 10.1161/circulationaha.109.872903

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837465

W. Ma-krupa, M. Jeon, S. Spoerl, T. Tedder, J. Goronzy et al., Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis, The Journal of Experimental Medicine, vol.42, issue.2, pp.173-83, 2004.
DOI : 10.1002/art.10071

P. Duhaut, S. Bosshard, A. Calvet, L. Pinede, S. Demolombe-rague et al., Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes, J Rheumatol. Feb, vol.26, issue.2, pp.361-370, 1999.
DOI : 10.1093/rheumatology/keh762

URL : http://rheumatology.oxfordjournals.org/cgi/content/short/44/suppl_3/iii17

K. Ly, E. Liozon, A. Fauchais, and E. Vidal, Physiopathologie de l???art??rite ?? cellules g??antes, La Revue de M??decine Interne, vol.34, issue.7, pp.392-402, 2013.
DOI : 10.1016/j.revmed.2013.02.037

K. Ly, A. Régent, M. Tamby, and L. Mouthon, Pathogenesis of giant cell arteritis: More than just an inflammatory condition?, Autoimmunity Reviews, vol.9, issue.10, pp.635-680, 2010.
DOI : 10.1016/j.autrev.2010.05.002

URL : https://hal.archives-ouvertes.fr/hal-00597708

J. Helweg-larsen, B. Tarp, N. Obel, and B. Baslund, No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis, Rheumatology, vol.41, issue.4, pp.445-454, 2002.
DOI : 10.1093/rheumatology/41.4.445

A. Rodriguez-pla, J. Bosch-gil, J. Echevarria-mayo, J. Rossello-urgell, R. Solans-laque et al., No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis, Journal of Clinical Virology, vol.31, issue.1, pp.11-16, 2004.
DOI : 10.1016/j.jcv.2004.05.003

R. Cooper, D. Arcy, S. Kirby, M. Buhtori, M. Rahman et al., Infection and temporal arteritis: A PCR-based study to detect pathogens in temporal artery biopsy specimens, Journal of Medical Virology, vol.75, issue.3, pp.501-506, 2008.
DOI : 10.1002/jmv.21092

A. Mohammadi, J. Pfeifer, and J. Lewis, Association between human papillomavirus DNA and temporal arteritis, BMC Musculoskeletal Disorders, vol.42, issue.2, p.132, 2012.
DOI : 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F

URL : http://doi.org/10.1186/1471-2474-13-132

R. Alvarez-lafuente, B. Fernández-gutiérrez, J. Jover, E. Júdez, E. Loza et al., Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction, Annals of the Rheumatic Diseases, vol.64, issue.5, pp.780-782, 2005.
DOI : 10.1136/ard.2004.025320

M. Nagel, J. Bennett, N. Khmeleva, A. Choe, A. Rempel et al., Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis, Neurology, vol.80, issue.22, 2013.
DOI : 10.1212/WNL.0b013e318294b477

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716402

M. Nagel, T. White, N. Khmeleva, A. Rempel, P. Boyer et al., Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis, JAMA Neurology, vol.72, issue.11, pp.1281-1288, 2015.
DOI : 10.1001/jamaneurol.2015.2101

F. Carmona, S. Mackie, J. Martín, J. Taylor, A. Vaglio et al., A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility, The American Journal of Human Genetics, vol.96, issue.4, pp.565-80
DOI : 10.1016/j.ajhg.2015.02.009

F. Carmona, J. Martin, and M. González-gay, New insights into the pathogenesis of giant cell arteritis and hopes for the clinic, Expert Review of Clinical Immunology, vol.12, issue.1, pp.57-66
DOI : 10.1586/1744666X.2016.1089173

F. Carmona, M. González-gay, and J. Martín, Genetic component of giant cell arteritis, Rheumatology, vol.53, issue.1, pp.6-18, 2014.
DOI : 10.1093/rheumatology/ket231

L. Rodríguez-rodríguez, F. Carmona, S. Castañeda, J. Miranda-filloy, I. Morado et al., Role of rs1343151 IL23R and rs3790567 IL12RB2 Polymorphisms in Biopsy-proven Giant Cell Arteritis, The Journal of Rheumatology, vol.38, issue.5, pp.889-92, 2011.
DOI : 10.3899/jrheum.101046

M. Schmidt, L. Pedersen, and H. Sørensen, The Danish Civil Registration System as a tool in epidemiology, European Journal of Epidemiology, vol.40, issue.40, pp.541-550, 2014.
DOI : 10.1007/s10654-014-9930-3

M. Schmidt, S. Schmidt, J. Sandegaard, V. Ehrenstein, L. Pedersen et al., The Danish National Patient Registry: a review of content, data quality, and research potential, Clinical Epidemiology, vol.7, pp.449-90
DOI : 10.2147/CLEP.S91125

B. Bjerregaard and O. Larsen, The Danish Pathology Register, Scandinavian Journal of Public Health, vol.39, issue.7 Suppl, 2011.
DOI : 10.1177/1403494810393563

V. Ehrenstein, S. Antonsen, and L. Pedersen, Existing data sources for clinical epidemiology: Aarhus University Prescription Database, Clinical Epidemiology, vol.2, pp.273-282, 2010.
DOI : 10.2147/CLEP.S13458

URL : http://doi.org/10.2147/clep.s13458

D. Misra and V. Agarwal, Innate immune cells in the pathogenesis of primary systemic vasculitis, Rheumatology International, vol.137, issue.2, pp.169-82
DOI : 10.1007/s00296-015-3367-1

P. Udayakumar, A. Chandran, C. Crowson, K. Warrington, and E. Matteson, Hospitalized Infections in Giant Cell Arteritis -- A Population-based Retrospective Cohort Study, The Journal of Rheumatology, vol.41, issue.12, pp.2447-51, 2014.
DOI : 10.3899/jrheum.140124

C. Michet, S. Achenbach, C. Crowson, and E. Matteson, Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012, Seminars in Arthritis and Rheumatism, vol.45, issue.1, pp.70-74, 2015.
DOI : 10.1016/j.semarthrit.2015.02.010

M. Durand and S. Thomas, Incidence of infections in patients with giant cell arteritis: A cohort study, Arthritis Care & Research, vol.27, issue.Suppl 1, pp.581-589
DOI : 10.1002/acr.21569

J. Schmidt, A. Smail, B. Roche, P. Gay, V. Salle et al., Severe infections during giant cell arteritis course: Incidence and mortality. The prospective, multicenter double cohort GRACG study, Arthritis Rheumatol. 2016, vol.68, issue.6, pp.1477-82

P. Udayakumar, A. Chandran, C. Crowson, K. Warrington, and E. Matteson, Hospitalized Infections in Giant Cell Arteritis -- A Population-based Retrospective Cohort Study, The Journal of Rheumatology, vol.41, issue.12, pp.2447-51, 2014.
DOI : 10.3899/jrheum.140124

V. Schäfer, T. Kermani, C. Crowson, G. Hunder, S. Gabriel et al., Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study, Rheumatology, vol.49, issue.11, pp.2104-2112, 2010.
DOI : 10.1093/rheumatology/keq200

B. Baslund, M. Helleberg, M. Faurschou, and N. Obel, Mortality in patients with giant cell arteritis, Rheumatology, vol.54, issue.1, pp.139-182
DOI : 10.1093/rheumatology/keu303

S. Unizoni, M. Menendez, N. Rastalsky, and J. Stone, Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency, Rheumatology, vol.54, issue.8, pp.1360-1368, 2015.
DOI : 10.1093/rheumatology/keu483

J. Ninan, A. Nguyen, A. Cole, M. Rischmueller, T. Dodd et al., Mortality in Patients with Biopsy-proven Giant Cell Arteritis: A South Australian Population-based Study, The Journal of Rheumatology, vol.38, issue.10, pp.2215-2222, 2011.
DOI : 10.3899/jrheum.101254

M. Russo, J. Waxman, A. Abdoh, and L. Serebro, Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum, pp.374-80, 1995.

G. Nesher, Autoimmune aspects of giant cell arteritis, Isr Med Assoc J, vol.16, issue.7, pp.454-459, 2014.

A. Soriano, E. Verrecchia, A. Marinaro, M. Giovinale, C. Fonnesu et al., Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature, Lupus, vol.48, issue.52, pp.153-160, 2012.
DOI : 10.1016/j.jaut.2010.10.004

J. Powers, S. Bedri, S. Hussein, R. Salomon, and A. Tischler, High Prevalence of Herpes Simplex Virus DNA in Temporal Arteritis Biopsy Specimens, American Journal of Clinical Pathology, vol.123, issue.2, 2005.
DOI : 10.1309/2996TT2CTLTKN0KT

A. Wagner, H. Gérard, T. Fresemann, W. Schmidt, E. Gromnica-ihle et al., Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells, Arthritis & Rheumatism, vol.43, issue.7, 2000.
DOI : 10.1002/1529-0131(200007)43:7<1543::AID-ANR19>3.3.CO;2-#

G. Rimenti, F. Blasi, R. Cosentini, O. Moling, R. Pristerà et al., Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen, J Rheumatol, vol.27, issue.11, pp.2718-2738, 2000.

B. Katz, C. Koening, B. Patel, C. Kim, K. Digre et al., Identification of Burkholderia in the Temporal Arteries and Blood of Patients with Giant Cell Arteritis, EHSL -NANOS Annual Meeting Collection [Internet]. 2012. Available from, 1377.

M. Van-timmeren, P. Heeringa, and C. Kallenberg, Infectious triggers for vasculitis, Current Opinion in Rheumatology, vol.26, issue.4, pp.416-439
DOI : 10.1097/BOR.0000000000000068